Literature DB >> 475950

Plasma pimozide profiles in chronic schizophrenics.

R G McCreadie, J J Heykants, A Chalmers, A M Anderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 475950      PMCID: PMC1429580          DOI: 10.1111/j.1365-2125.1979.tb01001.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  2 in total

1.  Differential effects of abrupt versus gradual withdrawal of chlorpromazine in hospitalized chronic schizophrenic patients.

Authors:  L M Greenberg; S Roth
Journal:  Am J Psychiatry       Date:  1966-08       Impact factor: 18.112

2.  High dosage haloperidol in chronic schizophrenia.

Authors:  R G McCreadie; I M MacDonald
Journal:  Br J Psychiatry       Date:  1977-09       Impact factor: 9.319

  2 in total
  5 in total

Review 1.  Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.

Authors:  A E Balant-Gorgia; L Balant
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

2.  Inhibition by various antipsychotic drugs of the G-protein-activated inwardly rectifying K(+) (GIRK) channels expressed in xenopus oocytes.

Authors:  T Kobayashi; K Ikeda; T Kumanishi
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

3.  Weekly Supervised Administration of Oral Antipsychotics: An Alternative to Long-Acting Injections?

Authors:  Sofia Brissos; David Taylor
Journal:  CNS Drugs       Date:  2022-02-28       Impact factor: 5.749

Review 4.  Pharmacokinetic optimisation of the treatment of psychosis.

Authors:  A E Balant-Gorgia; L P Balant; A Andreoli
Journal:  Clin Pharmacokinet       Date:  1993-09       Impact factor: 6.447

5.  Inhibition of wnt/β-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide.

Authors:  Valerie Fako; Zhipeng Yu; Curtis J Henrich; Tanya Ransom; Anuradha S Budhu; Xin W Wang
Journal:  Int J Biol Sci       Date:  2016-04-28       Impact factor: 6.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.